Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
Receivable days

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Receivable days History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   Receivable days 34.9133.8932.8935.35

What is the latest Receivable days ratio of CORONA REMEDIES ?

The latest Receivable days ratio of CORONA REMEDIES is 34.91 based on Mar2026 Consolidated results.
Year Receivable days
Mar202634.91
Mar202533.89
Mar202432.89
Mar202335.35

How is Receivable days of CORONA REMEDIES Trending?

Years Receivable days % Change
Mar2026 34.91
3.01
Mar2025 33.89
3.04
Mar2024 32.89
-6.96
Mar2023 35.35 -

Other Financial Ratios of CORONA REMEDIES


Compare Receivable days ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,423.3 Cr -4% -0.6% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-4%

-0.6%

NA
SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses